As Expected, ABI Completes Equity Investment in VisiGen

Dec 09, 2005

NEW YORK, Dec. 9 (GenomeWeb News) - Applied Biosystems said yesterday that it has completed its equity investment in VisiGen Biotechnologies.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.